Patent application number | Description | Published |
20090187231 | Electrical Treatment Of Bronchial Constriction - Devices, systems and methods for treating bronchial constriction related to asthma, anaphylaxis or chronic obstructive pulmonary disease wherein the treatment includes stimulating selected nerve fibers responsible for smooth muscle dilation at a selected region within a patient's neck, thereby reducing the magnitude of constriction of bronchial smooth muscle. | 07-23-2009 |
20090281593 | Electrical Treatment Of Bronchial Constriction - Devices, systems and methods for treating bronchial constriction related to asthma, anaphylaxis or chronic obstructive pulmonary disease wherein the treatment includes stimulating selected nerve fibers responsible for smooth muscle dilation at a selected region within a patient's neck, thereby reducing the magnitude of constriction of bronchial smooth muscle. | 11-12-2009 |
20100042178 | Electrical stimulation treatment of bronchial constriction - Methods and devices for treating bronchial constriction related to asthma and anaphylaxis wherein the treatment includes providing an electrical impulse to a selected region of the vagus nerve and/or the lungs of a patient suffering from bronchial constriction. | 02-18-2010 |
20100228318 | Electrical Stimulation Treatment of Bronchial Constriction - Methods and devices for treating bronchial constriction related to asthma and anaphylaxis wherein the treatment includes providing an electrical impulse to a selected region of the vagus nerve and/or the lungs of a patient suffering from bronchial constriction. | 09-09-2010 |
20100241188 | Percutaneous Electrical Treatment Of Tissue - Devices, systems and methods for applying electrical impulse(s) to one or more selected nerves in or around the carotid sheath are described. An electrode assembly is introduced through a percutaneous penetration in a patient to a target location adjacent to, or in close proximity with, the carotid sheath. Once in position, one or more electrical impulses are applied through the electrode assembly to one or more selected nerves to stimulate, block or otherwise modulate the nerve(s) and acutely treat the patient's condition. | 09-23-2010 |
20130172957 | NON-INVASIVE NERVE STIMULATOR CIRCUIT - The present disclosure describes a circuit that may be used in a non-invasive nerve stimulator. The circuit contains a signal source, a power source, an amplification source and a user interface portion. The circuit may be used in a handheld device that is applied directly to the surface of a patient or it may be used in other configurations. | 07-04-2013 |
20140343565 | ELECTRICAL TREATMENT OF BRONCHIAL CONSTRICTION - Devices, systems and methods for treating bronchial constriction related to asthma, anaphylaxis or chronic obstructive pulmonary disease wherein the treatment includes stimulating selected nerve fibers responsible for smooth muscle dilation at a selected region within a patient's neck, thereby reducing the magnitude of constriction of bronchial smooth muscle. | 11-20-2014 |
Patent application number | Description | Published |
20100056770 | PREPARATION OF NUCLEOSIDES RIBOFURANOSYL PYRIMIDINES - The present process provides an improved method for the preparation of 4-amino-1-((2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-hydrox-ymethyl-3-methyl-tetrahydro-furan-2-yl)-1H-pyrimidin-2-one of the formula (IV) which is a potent inhibitor of Hepatitis C Virus (HCV) NS5B polymerase. | 03-04-2010 |
20100279973 | SYNTHESIS OF PURINE NUCLEOSIDES - A process for preparing phosphoramidate prodrugs or cyclic phosphate prodrugs of nucleoside derivatives, which is a compound, its stereoisomers, salts (acid or basic addition salts), hydrates, solvates, or crystalline forms thereof. | 11-04-2010 |
20100298257 | NUCLEOSIDE PHOSPHORAMIDATES - Disclosed herein are nucleoside phosphoramidates and their use as agents for treating viral diseases. These compounds are inhibitors of RNA-dependent 5 RNA viral replication and are useful as inhibitors of HCV NS5B polymerase, as inhibitors of HCV replication and for treatment of hepatitis C infection in mammals. | 11-25-2010 |
20120316327 | SYNTHESIS OF PURINE NUCLEOSIDES - A process for preparing phosphoramidate prodrugs or cyclic phosphate prodrugs of nucleoside derivatives, which is a compound, its stereoisomers, salts (acid or basic addition salts), hydrates, solvates, or crystalline forms thereof. | 12-13-2012 |
Patent application number | Description | Published |
20100081628 | NUCLEOSIDE CYCLICPHOSPHATES - Cyclic phosphate of nucleoside derivatives for the treatment of viral infections in mammals, which is a compound, its stereoisomers, salts (acid or basic addition salts), hydrates, solvates, or crystalline forms thereof, represented by the following structure: | 04-01-2010 |
20110245484 | STEREOSELECTIVE SYNTHESIS OF PHOSPHORUS CONTAINING ACTIVES - Disclosed herein are phosphorus-containing actives, their use as actives for treating diseases, and a stereoselective process for preparing the same. Also disclosed herein are useful synthetic intermediates and processes for preparing the same. | 10-06-2011 |
20110251152 | NUCLEOSIDE PHOSPHORAMIDATES - Disclosed herein are nucleoside phosphoramidates and their use as agents for treating viral diseases. These compounds are inhibitors of RNA-dependent RNA viral replication and are useful as inhibitors of HCV NS5B polymerase, as inhibitors of HCV replication and for treatment of hepatitis C infection in mammals. | 10-13-2011 |
20110257121 | PURINE NUCLEOSIDE PHOSPHORAMIDATE - Disclosed herein is a compound represented by formula 1 or its hydrate thereof in crystalline or crystal-like form. | 10-20-2011 |
20120258928 | NUCLEOSIDE CYCLICPHOSPHATES - Cyclic phosphate of nucleoside derivatives for the treatment of viral infections in mammals, which is a compound, its stereoisomers, salts (acid or basic addition salts), hydrates, solvates, or crystalline forms thereof, represented by the following structure: | 10-11-2012 |
Patent application number | Description | Published |
20100034948 | Method of Making a Fruit Spread and Fruit Spread Composition - A method of making a fruit spread is provided that includes adding a first quantity of a particular fruit to a vessel, and adding a second quantity of concentrated juice of the particular fruit to the vessel. The method also includes adding a third quantity of another sweetener to the vessel to form a combination with the first and second quantities, and removing at least some of the water from the combination. A fruit spread made by the method is provided. A fruit spread is provided that includes first soluble solids from a particular fruit and second soluble solids a concentrated juice of the particular fruit. In the fruit spread, the first and second soluble solids represent between 5 and 99 percent by weight of an initial total soluble solids of the fruit spread. | 02-11-2010 |
20100203216 | Fruit Spread Composition - A fruit spread is provided that includes first soluble solids from a particular fruit having between 6 and 8 percent of soluble solids in a naturally occurring form, and second soluble solids from a concentrated form of the particular fruit. The first and second soluble solids are more than 7 percent by weight of the fruit spread. The fruit spread may include pectin. The particular fruit may have between 8 and 10 percent of soluble solids, and the first and second soluble solids may be more than 8.5 percent by weight of the fruit spread. The particular fruit may have more than 10 percent of soluble solids, and the first and second soluble solids may be more than 8.5 percent by weight of the fruit spread. | 08-12-2010 |
20100215827 | Fruit Spread Composition - A product is provided that includes total solids of more than 50 percent, in the range of 34 to 50 percent, or in the range of 18 to 34 percent, by weight of the product. In the product, the total solids comprise solids from a particular fruit in an amount greater than 5 percent, or in an amount greater than a higher percentage, by weight of the product. The particular fruit has between 6 and 8 percent solids, between 8 and 10 percent solids, or more than 10 percent solids in a naturally occurring form. | 08-26-2010 |
Patent application number | Description | Published |
20110047238 | PEER-TO-PEER MIXING SYSTEM AND METHOD - The system gets a request to add a communication node to an existing peer-to-peer communication session between two communication nodes. The communication node is added to the existing peer-to-peer communication session. The communication nodes in the existing peer-to-peer communication have not previously defined a mixing node. The communication nodes in the existing peer-to-peer communication session exchange a mixing score. A mixing node is determined based on the exchanged mixing score. Additional systems are defined which determine a mixing node when two peer-to-peer communication sessions are joined into a combined peer-to-peer communication session. | 02-24-2011 |
20110110362 | QUANTUM AND PROMISCUOUS USER AGENTS - A call processing system includes a call processing server. The call processing server processes calls for an internal network that employs SIP features and functions. The call processing server can receive calls from or send calls to one or more external communication endpoints that are not part of the internal network. However, the call processing server can associate a floating user agent with the communication from the external communication endpoint and lock the floating user agent to a gateway. After locking onto a gateway and initiating the call, the floating user agent can then publish call event status and receive SIP primitives similar to other SIP-enabled devices. | 05-12-2011 |
20130156026 | QUANTUM AND PROMISCUOUS USER AGENTS - A call processing system includes a call processing server. The call processing server processes calls for an internal network that employs SIP features and functions. The call processing server can receive calls from or send calls to one or more external communication endpoints that are not part of the internal network. However, the call processing server can associate a floating user agent with the communication from the external communication endpoint and lock the floating user agent to a gateway. After locking onto a gateway and initiating the call, the floating user agent can then publish call event status and receive SIP primitives similar to other SIP-enabled devices. | 06-20-2013 |
20130259026 | SYSTEM AND METHOD TO INFLUENCE SIP ROUTING BY SEQUENCED APPLICATIONS - System and method to influence routing of a call by a sequenced application from among a plurality of sequenced applications, the method including: receiving a header for the call, the header comprising at least one directive from one or more of the plurality of sequenced applications; arbitrating conflicts from among the at least one directive in the header, in order to determine a set of sequenced application headers to at least partially execute; and at least partially executing the set of sequenced application headers. | 10-03-2013 |
Patent application number | Description | Published |
20110189113 | Water-Resistant, Rub-Resistant, Sprayable Homogeneous Sunscreen Composition - In accordance with the present invention, there is provided a water-resistant, rub-resistant, sprayable, clear, and homogeneous sunscreen composition which includes an active sunscreen ingredient, alcohol, and a vinyl lactam or maleimide polymer soluble in the composition. | 08-04-2011 |
20120093748 | TOPICAL PERSONAL CARE AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF - Topical compositions are provided that have 0.5% or more of at least one personal care or pharmaceutical acid, and lightly- to moderately-crosslinked PVP, which is an effective thickener in the low pH systems. In preferred embodiments, the acid is a hydroxy acid and the composition used for personal care, or prescriptive or non-prescriptive medication indications for use on the skin, hair, scalp, foot, or lips. Also provided is the use of the topical compositions to deliver the acid(s) to the skin, hair, scalp, foot, or lips. Especially preferred is a use to reduce irritation and stinging compared to an equivalent compositions not having lightly- to moderately-crosslinked PVP. | 04-19-2012 |
20120219515 | SUN-CARE COMPOSITIONS - A sun-care composition having an SPF value of at least (15) containing (a) one or more sun-care actives; (b) a copolymer (or a terpolymer) containing (A) at least one vinyl pyrrolidone monomer and (i) at least one vinyl caprolactam monomer or (ii) at least one vinyl acetate monomer or (B) at least one vinyl caprolactam monomer and at least one vinyl acetate monomer; and (c) a pharmaceutically/cosmetically/dermatologically acceptable vehicle. | 08-30-2012 |
20120225106 | PERSONAL CARE COMPOSITIONS WITH SUSPENDED METAL OXIDES - Described herein are personal care compositions for use on the skin, hair, and lips that comprise: (A) at least one metal oxide, (B) lightly- to moderately-crosslinked PVP, and (C) at least one vehicle selected from the group consisting of: alcohols, esters, oils, glycols, and combinations thereof. The lightly- to moderately-crosslinked PVP suspends the metal oxide(s) whether or not water is added. Exemplary products embraced by the invention include sunscreens, diaper rash preparations, and anti-pruritic substances in the form of a lotion, cream, ointment, or gel. | 09-06-2012 |
20120294818 | Antiperspirant Compositions - Compositions containing a relatively high concentration of electrolytes and a thickening agent, wherein the thickening agent comprises a strongly swellable, lightly to moderately crosslinked polyvinyl pyrrolidone. The polyvinyl pyrrolidone thickening agent is characterized by an aqueous gel volume of about 15 to 150 ml/g and a Brookfield viscosity of at least 10,000 cps for a 5% aqueous solution at 25° C. | 11-22-2012 |
20130017160 | THICKENING ADDITIVE COMPOSITIONS - A thickening additive composition comprising: (A) a substantially anhydrous solvent system; and (B) a thickening agent, wherein the thickening agent comprises a strongly swellable, lightly to moderately crosslinked polyvinylpyrrolidone. Personal care compositions containing the thickening additive composition are also described. | 01-17-2013 |
20130243703 | SELF ADAPTING POLYMERS FOR ANHYDROUS SUNSCREEN FORMULATIONS - Compositions comprising sun-care actives and self adapting polymers are disclosed. Self adapting polymers align themselves with the hydrophilic group pointing to the surface during application thus delivering an aesthetically pleasing surface to the consumers with a pleasant after feel. These polymers then rearrange upon contact with water so that the hydrophobic groups now point to the surface which then increases the water resistance of the formulation. | 09-19-2013 |
20130336905 | COMPOSITIONS OF ENHANCED VISCOSITY, CLARITY, OR BOTH ENHANCED VISCOSITY AND CLARITY - Provided herein are compositions that exhibit enhanced clarity, higher viscosity, or both enhanced clarity and higher viscosity for a wide range of application arts, such as personal care compositions. The compositions have lightly- to moderately-crosslinked PVP and at least one additive. | 12-19-2013 |